Inpatient Care - Norway | Statista Market Forecast

The Inpatient Care market in Norway is predicted to experience substantial growth in the coming years.
According to projections, the revenue is expected to reach US$12.36bn in 2024.
Furthermore, a steady annual growth rate (CAGR 2024-2029) of 2.41% is anticipated, leading to a market volume of US$13.93bn by 2029.
When compared to other countries, it is worth noting that United States is set to generate the highest revenue in the Inpatient Care market sector.
In 2024 alone, United States is projected to generate a staggering US$731.40bn in revenue.
This highlights the dominance of the US market in terms of financial performance.
Norway's inpatient care market is characterized by a strong emphasis on patient-centered care and high-quality healthcare services.

Definition:
Inpatient Care refers to medical and surgical services provided to patients who are admitted for overnight stays at hospitals. This market covers a wide range of services, such as diagnostics, medical treatments, and surgical treatments. It also includes facilities, nursing care, and other services that are necessary for the patient's recovery and well-being during their hospital stay. However, inpatient long-term care (LTC) for people with LTC needs is not included. Hospital inpatient care is a crucial component of the healthcare industry and is essential for providing high-quality and comprehensive medical care to patients.

Structure:
Inpatient Care covers Neoplasm Treatments, Treatments of Cardiovascular Diseases, Treatments of Musculoskeletal Diseases, Gastroenterology, Midwifery, and Other Inpatient Care. Other Inpatient Care provides information on additional areas that are not covered by the previously mentioned markets.

Additional information:
Inpatient Care comprises revenues, average revenue per capita, number of hospitals, average revenue per hospital, number of hospital beds, and average revenue per hospital bed. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Inpatient nursing care
Medical goods for inpatient treatments
Inpatient surgical treatments

Day care
Long-term care
Outpatient care
Home-based care

The Inpatient Care market in Norway has been steadily developing in recent years.

Customer preferences: Norwegian consumers have a preference for high-quality healthcare services with a focus on patient-centered care. This has led to an increased demand for private hospital services, which offer a more personalized and comfortable patient experience. Additionally, the aging population in Norway has resulted in a greater need for long-term care facilities and specialized medical services.

Trends in the market: One trend in the Inpatient Care market in Norway is the shift towards digitalization and telemedicine. This has been accelerated by the COVID-19 pandemic, which has led to an increased use of remote consultations and virtual care. Another trend is the focus on sustainability and environmentally friendly practices in healthcare facilities. This includes the use of renewable energy sources, reducing waste, and implementing green building practices.

Local special circumstances: Norway has a well-developed healthcare system that is publicly funded and provides universal coverage. However, there is also a growing private healthcare sector that offers additional services and amenities. Additionally, Norway has a high cost of living and a strong economy, which allows for greater investment in healthcare infrastructure and technology.

Underlying macroeconomic factors: Norway has a strong economy with a high standard of living and a well-educated workforce. This has resulted in a high demand for healthcare services, particularly among the aging population. Additionally, the Norwegian government has made significant investments in healthcare infrastructure and technology, which has led to a more efficient and effective healthcare system. However, the cost of healthcare in Norway is also high, which has led to a greater focus on cost containment and efficiency measures.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The healthcare landscape in the United States is a complicated one. There are federal health insurance plans for low-income individuals namely Medicaid and CHIP (Children’s health insurance program) and Medicare for seniors and the disabled. Aside from these, people must buy private health insurance or be left uninsured because the U.S. is the only high-income country without universal healthcare coverage. Hospitals in the U.S., therefore, receive payment from multiple payers. Most revenue generated by U.S. hospitals comes from private insurance, self, or other payments. The complexity of this multi-payer system is instrumental to the U.S. having the highest administrative health costs per capita among wealthy nations.